The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study

por Bertuccio, Paola, Degli Antoni, Melania, Minisci, Davide, Amadasi, Silvia, Castelli, Francesco, Odone, Anna, Quiros-Roldan, Eugenia
Publicado 2023

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings

por Cattaneo, Dario, Sollima, Salvatore, Meraviglia, Paola, Milazzo, Laura, Minisci, Davide, Fusi, Marta, Filice, Carlo, Gervasoni, Cristina
Publicado 2020

Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?

por Gervasoni, Cristina, Meraviglia, Paola, Minisci, Davide, Ferraris, Laurenzia, Riva, Agostino, Landonio, Simona, Cozzi, Valeria, Charbe, Nitin, Molinari, Lara, Rizzardini, Giuliano, Clementi, Emilio, Galli, Massimo, Cattaneo, Dario
Publicado 2015

Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection

por Saulle, Irma, Ibba, Salomè Valentina, Torretta, Enrica, Vittori, Cecilia, Fenizia, Claudio, Piancone, Federica, Minisci, Davide, Lori, Elisa Maria, Trabattoni, Daria, Gelfi, Cecilia, Clerici, Mario, Biasin, Mara
Publicado 2019

Corrigendum: Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection

por Saulle, Irma, Ibba, Salomè Valentina, Torretta, Enrica, Vittori, Cecilia, Fenizia, Claudio, Piancone, Federica, Minisci, Davide, Lori, Elisa Maria, Trabattoni, Daria, Gelfi, Cecilia, Clerici, Mario, Biasin, Mara
Publicado 2019